CD274 and neoplasm: Both autonomous mechanisms (e.g., the low tumor mutational burden, downregulation of MHC genes and expression of PD-L1/PD-L2), as well as extrinsic properties (e.g., immunosuppressive TME), are at the origin of inconsistent clinical outcome.